Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Iversen

Showing results (91-100 of 226) with videos related to

Pageof 23
Sort By:
Acta Radiologica Open|September 9, 2015
Radiographic development during three decades in a patient with psoriatic arthritis mutilansLeena Laasonen, Björn Gudbjornsson, Leif Ejstrup, et al.
JAMA Dermatology|July 8, 2016
Association Between Changes in Coronary Artery Disease Progression and Treatment With Biologic Agents for Severe PsoriasisKasper Fjellhaugen Hjuler, Morten Bøttcher, Christian Vestergaard, et al.
Frontiers in Medicine|February 22, 2021
Comorbidities in a Cohort of 66 Patients With Psoriatic Arthritis Mutilans-Results From the Nordic PAM StudyJosephine Mistegård, Bjorn Gudbjornsson, Ulla Lindqvist, et al.
Acta Dermato-Venereologica|January 13, 2018
Systemic Inflammation and Evidence of a Cardio-splenic Axis in Patients with PsoriasisKasper F Hjuler, Lars C Gormsen, Mikkel H Vendelbo, et al.
JAMA Dermatology|June 1, 2022
Circulating Brodalumab Levels and Therapy Outcomes in Patients With Psoriasis Treated With Brodalumab: A Case SeriesChristian Enevold, Nikolai Loft, Anne Bregnhøj, et al.
Archives of Dermatological Research|March 15, 2019
Quality of life and contact with healthcare systems among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP)A Duvetorp, M Østergaard, L Skov, et al.
Journal of the American Academy of Dermatology|September 18, 2017
Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: Results through 108 weeks of a randomized, controlled phase 3 clinical trial (UNCOVER-3)Andrew Blauvelt, Melinda Gooderham, Lars Iversen, et al.
Cytokine|December 7, 2007
The expression of IL-20 and IL-24 and their shared receptors are increased in rheumatoid arthritis and spondyloarthropathyTue Wenzel Kragstrup, Kristian Otkjaer, Christian Holm, et al.
European Journal of Drug Metabolism and Pharmacokinetics|October 9, 2002
Non-linear mixed effects modeling of sparse concentration data from rats: application to a glycogen phosphorylase inhibitorSteen H Ingwersen, Benedicte Kiehr, Lars Iversen, et al.
Acta Dermato-Venereologica|August 8, 2018
Prevalence of Psoriasis and Psoriatic Arthritis and Patient Perceptions of Severity in Sweden, Norway and Denmark: Results from the Nordic Patient Survey of Psoriasis and Psoriatic ArthritisKjersti Danielsen, Albert Duvetorp, Lars Iversen, et al.
Pageof 23

Showing results (91-100 of 226) with videos related to

Sort By:
Pageof 23
Acta Radiologica Open|September 9, 2015
Radiographic development during three decades in a patient with psoriatic arthritis mutilansLeena Laasonen, Björn Gudbjornsson, Leif Ejstrup, et al.
JAMA Dermatology|July 8, 2016
Association Between Changes in Coronary Artery Disease Progression and Treatment With Biologic Agents for Severe PsoriasisKasper Fjellhaugen Hjuler, Morten Bøttcher, Christian Vestergaard, et al.
Frontiers in Medicine|February 22, 2021
Comorbidities in a Cohort of 66 Patients With Psoriatic Arthritis Mutilans-Results From the Nordic PAM StudyJosephine Mistegård, Bjorn Gudbjornsson, Ulla Lindqvist, et al.
Acta Dermato-Venereologica|January 13, 2018
Systemic Inflammation and Evidence of a Cardio-splenic Axis in Patients with PsoriasisKasper F Hjuler, Lars C Gormsen, Mikkel H Vendelbo, et al.
JAMA Dermatology|June 1, 2022
Circulating Brodalumab Levels and Therapy Outcomes in Patients With Psoriasis Treated With Brodalumab: A Case SeriesChristian Enevold, Nikolai Loft, Anne Bregnhøj, et al.
Archives of Dermatological Research|March 15, 2019
Quality of life and contact with healthcare systems among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP)A Duvetorp, M Østergaard, L Skov, et al.
Journal of the American Academy of Dermatology|September 18, 2017
Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: Results through 108 weeks of a randomized, controlled phase 3 clinical trial (UNCOVER-3)Andrew Blauvelt, Melinda Gooderham, Lars Iversen, et al.
Cytokine|December 7, 2007
The expression of IL-20 and IL-24 and their shared receptors are increased in rheumatoid arthritis and spondyloarthropathyTue Wenzel Kragstrup, Kristian Otkjaer, Christian Holm, et al.
European Journal of Drug Metabolism and Pharmacokinetics|October 9, 2002
Non-linear mixed effects modeling of sparse concentration data from rats: application to a glycogen phosphorylase inhibitorSteen H Ingwersen, Benedicte Kiehr, Lars Iversen, et al.
Acta Dermato-Venereologica|August 8, 2018
Prevalence of Psoriasis and Psoriatic Arthritis and Patient Perceptions of Severity in Sweden, Norway and Denmark: Results from the Nordic Patient Survey of Psoriasis and Psoriatic ArthritisKjersti Danielsen, Albert Duvetorp, Lars Iversen, et al.
Pageof 23